News

The 3rd Frontier Forum:New Therapeutics Discovery & Development

2016 Nov. 11th, Nanchang city, Jiangxi province, China The third Frontier Forum of New Therapeutics Discovery & Development was held successfully in Nanchang city, Jiangxi province, China. This is a serial forum hosted and organized by ShangPharma. The themes this...

ChemPartner and Trianni Announce Partnering Agreement

SAN FRANCISCO, Aug. 2, 2016 /PRNewswire/ — Trianni, Inc. (“TRIANNI”) and ChemPartner, a leading science-driven, technologically advanced, high-quality preclinical research partner, today announced an agreement designed to facilitate third-party access to The Trianni...

ShangPharma Congratulates Morphic Therapeutic

July 1, 2016 – SHANGHAI – ShangPharma , a leading China-based pharmaceutical and biotechnology research and development platform company serving healthcare industry, congratulates Morphic Therapeutic for accomplishing $51.5 Million Series A financing to develop...

ChemPartner at CPSA Shanghai 2016

The sixth Clinical & Pharmaceutical Solutions through Analysis (CPSA) was successfully held in Renaissance Shanghai Pudong Hotel on April 20th- 22th, 2016. More than 200 people were attracted, who are from multinational pharmaceutical companies, domestic CRO,...

San Diego, April 5-9, 2014, ChemPartner attended AACR.

The American Association for Cancer Research 2016 Annual Meeting,as one of the most important International tumor conference, was held in New Orleans on Apr 16th -20th .The topic was “Delivering Cures Through Cancer Science”. It is reported that more than 6000...

Headquarters

1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203

w

Contact Us

China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000

contact@chempartner.com